BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 19442073)

  • 1. Natriuretic peptide guided heart failure management.
    Mohammed AA; Januzzi JL
    Curr Clin Pharmacol; 2009 May; 4(2):87-94. PubMed ID: 19442073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natriuretic peptides: degradation, circulating forms, dosages and new therapeutic approaches.
    Favresse J; Gruson D
    Ann Biol Clin (Paris); 2017 Jun; 75(3):259-267. PubMed ID: 28446390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B-type natriuretic peptide in heart failure.
    Moe GW
    Curr Opin Cardiol; 2006 May; 21(3):208-14. PubMed ID: 16601459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The potential role of natriuretic peptides and other biomarkers in heart failure diagnosis, prognosis and management.
    Ibrahim N; Januzzi JL
    Expert Rev Cardiovasc Ther; 2015; 13(9):1017-30. PubMed ID: 26198476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic Accuracy of Natriuretic Peptides for Heart Failure in Patients with Pleural Effusion: A Systematic Review and Updated Meta-Analysis.
    Han ZJ; Wu XD; Cheng JJ; Zhao SD; Gao MZ; Huang HY; Gu B; Ma P; Chen Y; Wang JH; Yang CJ; Yan ZH
    PLoS One; 2015; 10(8):e0134376. PubMed ID: 26244664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Natriuretic peptides in heart failure].
    Almenar Bonet L; Martínez-Dolz L
    Rev Esp Cardiol; 2006 Jul; 6 Suppl F():15-26. PubMed ID: 17144974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Natriuretic peptides--when should they be used in heart failure?].
    Rottlaender D; Michels G; Hoppe UC
    Dtsch Med Wochenschr; 2008 Feb; 133(5):196-200. PubMed ID: 18213553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using biomarkers to guide heart failure management.
    Chang KW; Fox S; Mojaver S; Maisel AS
    Expert Rev Cardiovasc Ther; 2017 Oct; 15(10):729-741. PubMed ID: 28830266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natriuretic peptide-guided management of acutely destabilized heart failure: rationale and treatment algorithm.
    Bhardwaj A; Januzzi JL
    Crit Pathw Cardiol; 2009 Dec; 8(4):146-50. PubMed ID: 19952548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natriuretic peptides in the diagnosis and management of acute heart failure.
    Mohammed AA; Januzzi JL
    Heart Fail Clin; 2009 Oct; 5(4):489-500. PubMed ID: 19631174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natriuretic peptide-guided heart failure management.
    Troughton R; Michael Felker G; Januzzi JL
    Eur Heart J; 2014 Jan; 35(1):16-24. PubMed ID: 24216390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarker-guided treatment of congestive heart failure.
    Xue Y; Chan J; Sakariya S; Maisel A
    Congest Heart Fail; 2010 Jul; 16 Suppl 1():S62-7. PubMed ID: 20653714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monitoring the response to pharmacologic therapy in patients with stable chronic heart failure: is BNP or NT-proBNP a useful assessment tool?
    Balion CM; McKelvie RS; Reichert S; Santaguida P; Booker L; Worster A; Raina P; McQueen MJ; Hill S
    Clin Biochem; 2008 Mar; 41(4-5):266-76. PubMed ID: 17991434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The emerging role of natriuretic peptides in the diagnosis and treatment of decompensated heart failure.
    Gallagher MJ; McCullough PA
    Curr Heart Fail Rep; 2004 Sep; 1(3):129-35. PubMed ID: 16036036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natriuretic peptides and other biomarkers in chronic heart failure: from BNP, NT-proBNP, and MR-proANP to routine biochemical markers.
    Lainscak M; von Haehling S; Anker SD
    Int J Cardiol; 2009 Mar; 132(3):303-11. PubMed ID: 19144431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natriuretic peptides in heart failure and acute coronary syndrome.
    Gaggin HK; Januzzi JL
    Clin Lab Med; 2014 Mar; 34(1):43-58, vi. PubMed ID: 24507786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances in natriuretic peptide research.
    Woodard GE; Rosado JA
    J Cell Mol Med; 2007; 11(6):1263-71. PubMed ID: 18205700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atrial and brain natriuretic peptides: Hormones secreted from the heart.
    Nakagawa Y; Nishikimi T; Kuwahara K
    Peptides; 2019 Jan; 111():18-25. PubMed ID: 29859763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natriuretic peptides and heart failure in the patient with chronic kidney disease: a review of current evidence.
    Dhar S; Pressman GS; Subramanian S; Kaul S; Gollamudi S; Bloom EJ; Figueredo VM
    Postgrad Med J; 2009 Jun; 85(1004):299-302. PubMed ID: 19528304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multimarker Strategy for Heart Failure Prognostication. Value of Neurohormonal Biomarkers: Neprilysin vs NT-proBNP.
    Bayes-Genis A; Barallat J; Galán A; de Antonio M; Domingo M; Zamora E; Gastelurrutia P; Vila J; Peñafiel J; Gálvez-Montón C; Lupón J
    Rev Esp Cardiol (Engl Ed); 2015 Dec; 68(12):1075-84. PubMed ID: 26297179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.